These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8339777)

  • 1. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
    Gramsbergen JB; van der Sluijs-Gelling AJ
    Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic analysis of second messenger and neurotransmitter receptor bindings in the strionigral system of the postischemic rat brain.
    Nagasawa H; Araki T; Kogure K
    J Neurosci Res; 1992 Nov; 33(3):485-92. PubMed ID: 1335090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γ-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions.
    Rekik L; Daguin-Nerrière V; Petit JY; Brachet P
    J Neurosci Res; 2011 Apr; 89(4):524-35. PubMed ID: 21290407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections.
    Checa N; Canals JM; Alberch J
    Exp Neurol; 2000 Sep; 165(1):118-24. PubMed ID: 10964490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of 45Ca accumulation and [3H]inositol 1,4,5-trisphosphate binding using autoradiography in the exo-focal postischemic brain areas of the rat.
    Nagasawa H; Kogure K
    J Neurosci Res; 1992 Mar; 31(3):507-12. PubMed ID: 1640501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
    Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
    Rite I; Machado A; Cano J; Venero JL
    Exp Neurol; 2005 Mar; 192(1):142-55. PubMed ID: 15698628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium reduces the proapoptotic signaling associated to NF-kappaB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum.
    Santamaría A; Vázquez-Román B; La Cruz VP; González-Cortés C; Trejo-Solís MC; Galván-Arzate S; Jara-Prado A; Guevara-Fonseca J; Ali SF
    Synapse; 2005 Dec; 58(4):258-66. PubMed ID: 16206188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
    Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL
    J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia.
    Checa N; Canals JM; Gratacòs E; Alberch J
    Exp Neurol; 2001 Dec; 172(2):282-92. PubMed ID: 11716553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral quinolinic acid injection in the rat: effects on dopaminergic neurons.
    Mazzari S; Aldinio C; Beccaro M; Toffano G; Schwarcz R
    Brain Res; 1986 Aug; 380(2):309-16. PubMed ID: 2944562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
    Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
    Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration.
    Pérez P; Flores A; Santamaría A; Ríos C; Galván-Arzate S
    Arch Med Res; 1996; 27(4):449-52. PubMed ID: 8987176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-course analysis and comparison of acute and chronic intrastriatal quinolinic acid administration on forelimb reaching deficits in the rat.
    Bazzett T; Legnard E; Bauter MR; Albin RL
    Exp Neurol; 1999 Jul; 158(1):126-34. PubMed ID: 10448424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quinolinic acid administered during pregnancy on the brain of offspring.
    Beskid M
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):323-7. PubMed ID: 7894243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium accumulation following middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats.
    Shirotani T; Shima K; Iwata M; Kita H; Chigasaki H
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):831-6. PubMed ID: 8063878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.
    Ryu JK; Jantaratnotai N; McLarnon JG
    Neuroscience; 2009 Oct; 163(2):601-8. PubMed ID: 19591904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.